Clinical Trial Update: A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 2 safety and tolerability study of 10XB-101 injections in adults with submental fat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• 10XB-101 injection

Snippet

Sponsor: 10xBio, LLC | Conditions: Submental Fat | Phase 2 | Status: COMPLETED